These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17886255)

  • 21. Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.
    Flamini MI; Sanchez AM; Goglia L; Tosi V; Genazzani AR; Simoncini T
    Mol Hum Reprod; 2009 Oct; 15(10):675-85. PubMed ID: 19541800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs.
    Zhao L; O'Neill K; Diaz Brinton R
    Brain Res Brain Res Rev; 2005 Nov; 49(3):472-93. PubMed ID: 16269315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
    Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-genomic actions of estrogens and their interaction with genomic actions in the brain.
    Vasudevan N; Pfaff DW
    Front Neuroendocrinol; 2008 May; 29(2):238-57. PubMed ID: 18083219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogens and growth.
    Simm PJ; Bajpai A; Russo VC; Werther GA
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):32-41. PubMed ID: 18806723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.
    Härkönen PL; Väänänen HK
    Ann N Y Acad Sci; 2006 Nov; 1089():218-27. PubMed ID: 17261769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling.
    Kajta M; Wójtowicz AK; Maćkowiak M; Lasoń W
    Neuroscience; 2009 Jan; 158(2):811-22. PubMed ID: 19027052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nongenomic actions of estrogens: exciting opportunities for pharmacology.
    Wehling M; Schultz A; Lösel R
    Maturitas; 2006 Jul; 54(4):321-6. PubMed ID: 16730139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes.
    Björnström L; Sjöberg M
    Mol Endocrinol; 2005 Apr; 19(4):833-42. PubMed ID: 15695368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.
    Manavathi B; Kumar R
    J Cell Physiol; 2006 Jun; 207(3):594-604. PubMed ID: 16270355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
    Hagen ML; Hellmers M; Abrahamsen B; Hagen C
    Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
    Sheldahl LC; Marriott LK; Bryant DM; Shapiro RA; Dorsa DM
    Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular matrix integrity: a possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens?
    Cox DA; Helvering LM
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):53-9. PubMed ID: 16426741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dual, opposing roles of estrogen in the prostate.
    Ellem SJ; Risbridger GP
    Ann N Y Acad Sci; 2009 Feb; 1155():174-86. PubMed ID: 19250203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen, selective estrogen receptor modulators and now mechanism-specific ligands of the estrogen or androgen receptor?
    Khosla S
    Trends Pharmacol Sci; 2003 Jun; 24(6):261-3. PubMed ID: 12823947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Board-invited review: Estrogen and progesterone signaling: genomic and nongenomic actions in domestic ruminants.
    Stormshak F; Bishop CV
    J Anim Sci; 2008 Feb; 86(2):299-315. PubMed ID: 17965328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensing estrogen's many pathways.
    Weatherman RV
    ACS Chem Biol; 2008 Jun; 3(6):338-40. PubMed ID: 18570353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.
    Katzenellenbogen BS; Katzenellenbogen JA
    Breast Cancer Res; 2000; 2(5):335-44. PubMed ID: 11250726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogens in human vascular diseases.
    Klouche M
    Ann N Y Acad Sci; 2006 Nov; 1089():431-43. PubMed ID: 17261786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.